DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Gerald Crabtree - 1 ” - 1 Crabtree - 1 Nathanael S - 1 Gray - 1 “ - 1 Jason Gestwicki - 1 Paul Biondi - 1
Top related locs:
Santa Cruz San Francisco Bengaluru New Jersey
Top related orgs:
Foghorn Therapeutics - 2 Stanford - 1 redwoods - 1 University of California - 1 drugmaker Pfizer - 1 Moderna Inc - 1 Pfizer - 1 Flagship's - 1

Search resuls for: "Foghorn Therapeutics"


2 mentions found


☆ Flipping a Switch and Making Cancers Self-Destruct
  + stars: | 2023-07-26 | by ( Gina Kolata | More About Gina Kolata | ) www.nytimes.com   time to read: +1 min
Within every cancer are molecules that spur deadly, uncontrollable growth. What if scientists could hook those molecules to others that make cells self-destruct? Could the very drivers of a cancer’s survival instead activate the program for its destruction? “It’s very cool,” said Jason Gestwicki, professor of pharmaceutical chemistry at the University of California, San Francisco. “It turns something the cancer cell needs to stay alive into something that kills it, like changing your vitamin into a poison.”
Persons: Gerald Crabtree, ”, Crabtree, Nathanael S, Gray, “, Jason Gestwicki Organizations: Stanford, redwoods, Foghorn Therapeutics, University of California Locations: Santa Cruz, San Francisco
☆ Pfizer, Flagship Pioneering to invest $100 mln in drug discovery
  + stars: | 2023-07-18 | by ( ) www.reuters.com   time to read: +2 min
July 18 (Reuters) - U.S. drugmaker Pfizer (PFE.N) and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential drugs for areas including internal medicine, oncology, infectious diseases and immunology. Flagship, which has incubated biotech companies, most famously Moderna Inc (MRNA.O), and Pfizer will each invest $50 million. Flagship's drug discovery initiative Pioneering Medicines will lead the exploration process. Paul Biondi, president of Flagship's Pioneering unit and a former top Bristol Myers Squibb (BMY.N) executive, said the partnership will take advantage of Flagship's abilities to develop novel technologies towards bigger disease areas. Drug developers such as Denali Therapeutics (DNLI.O), Foghorn Therapeutics (FHTX.O) and Sana Biotechnology (SANA.O) are some of the other companies backed by Flagship.
Persons: Paul Biondi, Biondi, Mikael Dolsten, Foghorn, Bhanvi, Michael Erman, Shilpi Majumdar, Alexandra Hudson Organizations: drugmaker Pfizer, Moderna Inc, Pfizer, Flagship's, Bristol Myers Squibb, Flagship, Therapeutics, Foghorn Therapeutics, Sana Biotechnology, Alexandra Hudson Our, Thomson Locations: Bengaluru, New Jersey
0 next >>
Total: 2